Skip to content

Released Aug 2, 2023, after the close

10-Q filed Aug 3, 2023, 34 days after period end · 0001653477-23-000047

Q2 2023 · 10-Q
Revenue$481.80M+14.7% vs Q2 2022+22.7% vs Q1 2023
Net Income$35.50M−40.6% vs Q2 2022−30.0% vs Q1 2023
EPS Diluted$0.97−37.0% vs Q2 2022−28.1% vs Q1 2023
Gross Profit$153,000,000+1.6%
Operating Income$120,700,000−0.3%
Operating Cash Flowderived$48,400,000−46.5%
Free Cash Flowderived$26,700,000−56.2%
Margins · derived
Gross margin31.8%−4.1 pt vs Q2 2022
Operating margin25.1%−3.8 pt vs Q2 2022
Net margin7.4%−6.9 pt vs Q2 2022

What the release said

The release

Same quarter

MetricQ2 2023Q2 2022Q2 2021Q2 2020
Revenue$481.80M$419.90M$358.40M$270.60M
Net Income$35.50M$59.80M$44.30M$20.20M
EPS Diluted$0.97$1.54$1.10$0.49

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR